Amarasinghe, Gaya K.
- Washington University in St. Louis · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #441
- Sustained Excellence
- Program Leader
- Top 5% Funded
- R01 Holder
- Long-Funded
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$7M
Full award amounts, FY2023
Award Records
8
Records listing this PI
Award-Linked Rank
#441
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Amarasinghe, Gaya K. as a PI. Multi-PI records show the full award amount for context.
- 2P01AI120943-06A1P01Contact PIMolecular Mechanisms of Filoviral-host InteractionsWashington University in St. Louis · Pathology (NIH department code)$3.4Maward amount
- 1R01AI169850-01A1R01Contact PICharacterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyavirusesWashington University in St. Louis · Pathology (NIH department code)$783.6Kaward amount
- 5R01AI143292-05R01Contact PINovel VP30-host Interactions that Negatively Regulate Ebola Virus InfectionWashington University in St. Louis · Pathology (NIH department code)$762.1Kaward amount
- 5R01AI161765-03R01Contact PIIdentification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and PathogenesisWashington University in St. Louis · Pathology (NIH department code)$739.5Kaward amount
- 5R01AI161374-03R01Contact PIDevelopment and characterization of engineered therapeutic antibodies against SARS-CoV-2Washington University in St. Louis · Pathology (NIH department code)$638.7Kaward amount
- 3R01AI161374-03S1R01Contact PIDevelopment and characterization of engineered therapeutic antibodies against SARS-CoV-2Washington University in St. Louis · Pathology (NIH department code)$388.8Kaward amount
- 1R21AI176626-01A1R21Contact PIHSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.Washington University in St. Louis · Pathology (NIH department code)$247.7Kaward amount
- 3R01AI143292-05S1R01Contact PINovel VP30-host Interactions that Negatively Regulate Ebola Virus InfectionWashington University in St. Louis · Pathology (NIH department code)$61.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Amarasinghe, Gaya K. as a PI.
FY2023 award administered by Washington University in St. Louis (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardWashington University in St. Louis
- 2010$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2013R01 Grant Holder
- 2016$2M Cumulative Funding
- 2016$5M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #1085
- 2016Entered Top 25% NationallyRanked #1085
- 2016Entered Top 10% NationallyRanked #1085
- 2017Entered Top 5% NationallyRanked #737
- 2017Program/Center Grant Leader
- 2018$10M Cumulative Funding
- 2023$25M Cumulative Funding